Engineers Gate Manager LP Vanda Pharmaceuticals Inc. Transaction History

Engineers Gate Manager LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.47 - $4.61 $67,127 - $89,180	19,345 New	19,345 $79,000
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $166,136 - $255,027	38,817 Added 173.89%	61,140 $264,000
Q2 2023 Aug 14, 2023	BUY	$5.9 - $6.95 $28,184 - $33,200	4,777 Added 27.23%	22,323 $147,000
Q1 2023 May 15, 2023	SELL	$6.18 - $7.99 $127,555 - $164,913	-20,640 Reduced 54.05%	17,546 $119,000
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $262,337 - $418,518	38,186 New	38,186 $282,000
Q2 2022 Aug 15, 2022	BUY	$9.31 - $11.84 $295,313 - $375,564	31,720 New	31,720 $346,000
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $154,795 - $236,334	-14,280 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $224,053 - $301,879	14,280 New	14,280 $224,000
Q2 2021 Aug 16, 2021	SELL	$15.71 - $21.51 $340,435 - $466,121	-21,670 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$13.42 - $20.28 $290,811 - $439,467	21,670 New	21,670 $325,000
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $300,163 - $424,284	-30,723 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.32 - $12.02 $175,523 - $226,372	18,833 Added 158.39%	30,723 $297,000
Q2 2020 Aug 17, 2020	BUY	$9.66 - $12.02 $114,857 - $142,917	11,890 New	11,890 $136,000
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $304,659 - $429,919	-24,609 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$12.27 - $15.79 $12,257 - $15,774	999 Added 4.23%	24,609 $327,000
Q2 2019 Aug 14, 2019	BUY	$13.37 - $18.85 $315,665 - $445,048	23,610 New	23,610 $333,000

156

45.1M

136K

220K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $257M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.